<DOC>
	<DOCNO>NCT00499070</DOCNO>
	<brief_summary>RATIONALE : Studying biopsy , bone marrow , blood sample patient cytopenia respond treatment may help doctor learn disease plan best treatment . PURPOSE : This laboratory study assess immune function young patient cytopenia respond treatment .</brief_summary>
	<brief_title>Assessing Immune Function Young Patients With Cytopenia That Did Not Respond Treatment</brief_title>
	<detailed_description>OBJECTIVES : Primary - To evaluate value TCR V beta repertoire analysis determination autoimmunity refractory cytopenia ( RC ) . - To evaluate immunophenotypic hematopoietic subclones associate oligoclonal T-cell expansion RC . - To evaluate presence paroxysmal nocturnal hemoglobinuria ( PNH ) clone RC . Secondary - To compare molecular response hematologic response patient RC treatment immunosuppressive therapy ( IST ) . - To compare molecular response human leukocyte histocompatability antigen ( HLA ) expression patient RC treatment IST . OUTLINE : This open-label , multicenter , nonrandomized , prospective study . Patients undergo biopsy , bone marrow , blood sample collection periodically immunological study . Samples analyze TCR V beta repertoire paroxysmal nocturnal hemoglobinuria ( PNH ) clone analysis via PCR heteroduplex analysis immunophenotyping CD14 , CD16 , CD55 , CD59 , CD24 expression via flow cytometry .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Fanconi Anemia</mesh_term>
	<mesh_term>Fanconi Syndrome</mesh_term>
	<mesh_term>Dyskeratosis Congenita</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Lipomatosis</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Lipid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis refractory cytopenia ( RC ) include follow : Severe aplastic anemia ( SAA ) Fanconi 's anemia Shwachman Diamond syndrome Dyskeratosis congenita Pearson syndrome All RC patient include EWOG MDS 2006 protocol irrespective therapy Patients undergone hematopoietic stem cell transplantation ( HSCT ) may enrol EWOGMDS SCT RC RIC 06 EWOGMDS SCT MDS 06 protocol PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : No prior immunosuppressive therapy refractory cytopenia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>refractory cytopenia multilineage dysplasia</keyword>
	<keyword>aplastic anemia</keyword>
	<keyword>Fanconi anemia</keyword>
	<keyword>dyskeratosis congenita</keyword>
	<keyword>Shwachman-Diamond syndrome</keyword>
	<keyword>Pearson marrow-pancreas syndrome</keyword>
</DOC>